Although rapidly rising pharmaceutical costs have contributed to increased health expenditures nationwide, few studies have examined this trend in children with special health care needs. This study used data from two large commercial managed care plans in UnitedHealth Group to examine how many...

The Medicare Part D coverage gap has been associated with lower adherence and drug utilization and higher discontinuation. Because osteoporosis has a relatively high prevalence among Medicare-eligible postmenopausal women, we examined changes in utilization of osteoporosis medications during...

This brief presents noteworthy trends and patterns in the use and costs of prescription drugs for Medicaid beneficiaries from 1999 to 2009. It builds on previous annual tables and chartbooks, and describes trends in drug usage and costs. The brief emphasizes trends for beneficiaries with...

Reports on a survey of eligible entities—including disproportionate share hospitals, federally qualified health centers, community health centers, migrant health centers, and others—on their understanding of the Public Health Service drug pricing program, their decision to...

Antidepressant drugs are widely prescribed in the United States; however, little is known about their use among major ethnic minority groups. Collaborative Psychiatric Epidemiology Surveys (CPES) data were analyzed to calculate nationally representative estimates of Latino and non-Latino white...

This technical assistance brief, prepared for the Integrated Care Resource Center, provides basic information for states participating in the Centers for Medicare & Medicaid Services’ capitated Financial Alignment Demonstration covering Medicare-Medicaid enrollees. Although not a...